Arrowhead Pharmaceuticals Inc (NASDAQ:ARWR)

Delayed Data
As of Sep 22
 +0.02 / +0.07%
Today’s Change
Today|||52-Week Range

Stock Price Forecast

The 14 analysts offering 12-month price forecasts for Arrowhead Pharmaceuticals Inc have a median target of 59.50, with a high estimate of 90.00 and a low estimate of 27.00. The median estimate represents a +118.35% increase from the last price of 27.25.

Analyst Recommendations

The current consensus among 14 polled investment analysts is to Buy stock in Arrowhead Pharmaceuticals Inc. This rating has held steady since September, when it was unchanged from a Buy rating.Move your mouse over past
months for detail


Earnings and Sales Forecasts

Current Quarter

Earnings per Share
Reporting Date
Nov 27

Earnings per Share

Move your mouse over a quarter or year to see how estimates have changed over time.

Growthquarterly 28.18%
Growthannually 26.39%


Growthquarterly 160.17%
Growthannually 16.51%
Key to the earnings and sales forecast charts.